Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 73.30%
March 31, 2026 33.56%
December 31, 2025 70.75%
September 30, 2025 34.50%
June 30, 2025 72.16%
March 31, 2025 71.62%
December 31, 2024 73.41%
September 30, 2024 71.59%
June 30, 2024 69.24%
March 31, 2024 69.45%
December 31, 2023 69.99%
September 30, 2023 69.96%
June 30, 2023 68.74%
March 31, 2023 68.20%
December 31, 2022 65.73%
September 30, 2022 67.79%
June 30, 2022 68.00%
March 31, 2022 67.44%
December 31, 2021 64.97%
September 30, 2021 62.62%
June 30, 2021 64.16%
March 31, 2021 66.49%
December 31, 2020 70.25%
September 30, 2020 69.63%
June 30, 2020 71.20%
Date Value
March 31, 2020 65.43%
December 31, 2019 68.43%
September 30, 2019 6.20%
June 30, 2019 4.91%
March 31, 2019 7.15%
December 31, 2018 6.70%
September 30, 2018 5.32%
June 30, 2018 5.98%
March 31, 2018 68.03%
December 31, 2017 7.18%
September 30, 2017 5.90%
June 30, 2017 6.04%
March 31, 2017 69.22%
December 31, 2016 70.55%
September 30, 2016 68.83%
June 30, 2016 69.30%
March 31, 2016 68.33%
December 31, 2015 9.00%
September 30, 2015 6.37%
June 30, 2015 7.25%
March 31, 2015 8.10%
December 31, 2014 9.19%
September 30, 2014 7.04%
June 30, 2014 7.72%
March 31, 2014 8.21%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
The Ensign Group, Inc. 14.47%
Regional Health Properties, Inc. 27.39%
Chemed Corp. 30.37%
Oncologix Tech, Inc. --
InnovAge Holding Corp. 21.46%

Gross Profit Margin (Quarterly) Related Metrics